Delivery Systems and the Deep Beauty Consumer
During the conference, Anne Mu, Applied Technology Manager of the Care Solutions Business Line, will provide a podium presentation entitled “Skin Care & Beyond: Encapsulation & Controlled Release of Skin Actives.” The presentation will discuss the challenges Active ingredients have in their path towards efficacy on skin, the advantages that delivery technology brings to address some of these challenges, and the performance enhancement that select types of delivery technologies can yield.
At the event’s Technology Showcase, Evonik will also be presenting a poster entitled “Addressing Consumers’ Search for Deep Beauty Solutions” which suggests that delivery systems could be a good option to meet needs of the new Deep Beauty Consumer. These consumers are seeking solutions that provide more fundamental skin health appearance benefits. They seek wellness and ascribe to ‘health as the new wealth’ but are pragmatic in balancing science and observable results with aspirational aspects of products. The rapid growth of dermacosmetics is in part a response to this search for more fundamental, science-based solutions. And these consumers are savvy and confident in their ability to learn and evaluate product benefits through what they read from the Internet, making the selection of ingredient technology ever more important. Delivery systems offer an effective way to enhance cosmetic formulation performance through an approach that is understandable and intuitive for consumers. To help formulators leverage these technologies, the poster previews Evonik’s forthcoming market concept, deepBeauty Inspirations, which illustrates how formulators can use delivery technologies in their formulations.
Protection from Stressors and Harmful Bacteria
Evonik will also present two additional posters in the Technology Showcase.
“Keep Stressors at Bay through Bio-Inspired Solutions” showcases four Evonik products, each using a different underlying bio-inspired chemistry or technology, to address skin stressors such as blue light and free radicals. The products featured are:
- newly launched ROVISOME® Sensitive NG for reduction of irritation caused by cosmetic ingredients like retinol
- NeoPlanta® Withania for protection from pollution and other lifestyle stressors through a certified-natural, biotechnologically-grown plant extract
- TEGO® Turmerone for antioxidant benefits without the odor and color profile commonly associated with other turmerone qualities
- TEGO® Pep UP for blue-light protection
“Preservation across the Panoramic Cosmetic Landscape” provides formulators with a useful view of both alternative and conventional preservation solutions for use across different formulation types. The poster focuses on Evonik Dr. Straetmans’ dermosoft® and Verstatil® preservation solutions.
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world. In fiscal 2018, the enterprise with more than 32,000 employees generated sales of €13.3 billion and an operating profit (adjusted EBITDA) of €2.15 billion from continuing operations.
About Nutrition & Care
The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 8,200 employees, and generated sales of around
€4.6 billion in 2018.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.